Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 Kinetiq Kinetiq +3.41%
#6 Test Test +3.32%
#7 Movement Movement +3.31%
#8 Victoria VR Victoria VR +3.17%
#9 Jito Jito +3.05%
#10 COTI COTI +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Arno Therapeutics, Inc. Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

ARNI
Rang in Aktien #42094
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a... Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid tumors and hematological malignancies. Additionally, it is in pre-clinical development for potential applications against a range of microbial targets. AR-42, another innovative oral cancer treatment, is involved in a Phase I investigator-initiated clinical study, targeting both hematological malignancies and solid tumors. To support its research and development efforts, Arno Therapeutics has established licensing agreements with Invivis Pharmaceuticals, Inc., the Regents of the University of Minnesota, and the Ohio State University Innovation Foundation. The company also holds a co-development partnership with Leica Biosystems Newcastle Ltd.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$4.94K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Arno Therapeutics, Inc. (ARNI)

Kategorie

Healthcare
Preis ARNI mit Marktkapitalisierung von B
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
ARNI
$0.0001
Marktkapitalisierung von Arno Therapeutics, Inc.(ARNI)
Marktkapitalisierung: $4.94K
Mit Stand August 2026 hat Arno Therapeutics, Inc. eine Marktkapitalisierung von $4.94K. Das macht Arno Therapeutics, Inc. laut unseren Daten zum 42094th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Arno Therapeutics, Inc. von 2008 bis 2026
ARNI im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ARNI Vermögenswert B Marktkapitalisierung von B Ergebnisse
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$109,085 $4.94K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +109,085,297,974.98%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$89,633.05 $4.94K
Apple Inc. Apple Inc.
AAPL
$4.423T +89,633,053,673.82%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$84,303.33 $4.94K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +84,303,331,188.39%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$74,231.43 $4.94K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +74,231,425,168.49%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$58,586.20 $4.94K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +58,586,196,362.01%